Brief: Neurovive redirects research resources from Asian subsidiary to parent company
25/01/2017 07:30
Jan 25 (Reuters) - Neurovive Pharmaceutical AB NVP.ST
* Neurovive redirects research resources from Asian
subsidiary to parent
* Says under agreement, Neurovive Pharmaceutical AB will
receive approximately 5 million SEK before transaction costs
* Says in addition, Neurovive and its collaboration partner
Foundation Asia Pacific LTD. Will reacquire Hong Kong based
subsidiary, Neurovive Pharmaceutical Asia LTD.
* Says Hong Kong company will be owned by Neurovive
Pharmaceutical AB (approx. 82.5%) and Foundation Asia Pacific
LTD. (approx. 17.5%)
* Says on closing, other assets previously licensed to the
NeuroVive Asia group will be returned to NeuroVive
Pharmaceutical AB.
Source text for Eikon: ID:nWkrax4941
Further company coverage: NVP.ST
(Stockholm Newsroom)
((stockholm.newsroom@thomsonreuters.com; +46 (0)8-700 10 10;))